Procter & Gamble reported adjusted earnings per share of $1.88 for its fiscal second quarter, exceeding consensus forecasts by $0.02. Net sales reached $22.21 billion versus analyst projections of $22.36 billion, while net margin held at 19.74% and return on equity measured 32.63%. The company’s shares climbed following the report, with daily trading volume jumping 46% to over 18 million shares, compared with an average of 12.4 million.

Organic sales were flat year-over-year as a 1% gain from pricing was fully offset by a 1% volume decline. By segment, Beauty grew 4% on premium mix and innovation in Asia and North America, Health Care rose 3% driven by Oral Care premium products, Grooming and Fabric & Home Care held steady, and Baby, Feminine & Family Care fell 4% reflecting lower birth rates in key markets.

The board declared a quarterly dividend of $1.0568 per share, translating to an annualized payout of $4.23 and a 2.8% yield, with a payout ratio of 61.8%. Operating cash flow for the quarter totaled $5.0 billion, free cash flow productivity ran at 88%, and the company returned $4.8 billion to shareholders via $2.5 billion in dividends and $2.3 billion in share buybacks.

Management reaffirmed full-year adjusted earnings guidance of $6.83 to $7.09 per share and maintained organic sales growth outlook of 0%–4%. Meanwhile, several brokerages adjusted their targets: Wells Fargo trimmed its target to $158, JPMorgan to $157 and UBS to $161, while consensus among research firms remains a moderate-buy view with an average target near $166.